分析经腹腔镜下全盆底重建术对盆腔器官脱垂（POP）的疗效。

选取2019年1月至2022年1月于淮安第一医院收治的POP患者90例作为研究对象，按照手术方法分为对照组（44例）和观察组（46例）。对照组患者行阴道子宫切除术联合阴道前后壁修补术，观察组患者行钛涂层聚丙烯网片（TiLOOP）经腹腔镜植入全盆底重建术。比较2组患者手术情况、疼痛情况、盆底肌力、生活质量、并发症情况及预后情况。

观察组术中出血量（24.38±7.14）ml、导尿管留置时间（2.39±0.62）d、术后住院时间（5.84±1.52）d少于对照组（46.22±10.76）ml、（3.06±0.72）d、（7.17±1.98）d，手术时间（131.29±28.47）min长于对照组（98.54±21.36）min，差异均有统计学意义（P<0.05）。观察组自感疼痛持续时间（3.86±0.45）d、术后12 h视觉模拟评分（VAS）（4.29±0.47）分，低于对照组的（4.17±0.59）d、（4.66±0.79）分，差异均有统计学意义（P<0.05）。术后6个月，观察组肌电位（14.19±2.13）μV、静态张力（156.49±21.83）g/cm²、动态张力（231.56±28.44）g/cm²，高于对照组的（12.98±1.95）μV、（144.92±22.64）g/cm²、（216.47±27.08）g/cm²，差异均有统计学意义（P<0.05）。术后12个月，观察组盆腔器官脱垂困扰量表6（6.83±1.51）分、结直肠肛门困扰量表8（2.27±0.62）分、排尿困扰量表-6（6.76±1.13）分，低于对照组的（7.65±1.79）分、（2.61±0.83）分、（7.43±1.89）分，差异均有统计学意义（P<0.05）。2组并发症发生率、POP复发率差异无统计学意义（P>0.05）。

腹腔镜TiLOOP网片全盆底重建术较传统术式减少术中出血，缩短术后恢复时间，减轻疼痛，提升患者盆底肌力，改善生活质量，且未增加并发症。

To analyze the efficacy of total pelvic floor reconstruction via laparoscopy for pelvic organ prolapse (POP).

Ninety POP patients with POP admitted to Huai'an First Hospital between January 2019 and January 2022 were enrolled and divided into a control group (44 cases) and an observation group (46 cases) according to surgical methods. Patients in the control group underwent vaginal hysterectomy combined with anterior and posterior vaginal wall repair. Patients in the observation group underwent total pelvic floor reconstruction with titanium-coated polypropylene (TiLOOP) mesh implantation via laparoscopy. Surgical outcomes, pain levels, pelvic floor muscle strength, quality of life, complications, and prognosis were compared between the two groups.

The observation group showed less intraoperative blood loss (24.38±7.14) ml, shorter indwelling catheter time (2.39±0.62) days, and shorter postoperative hospital stay (5.84±1.52) days compared to the control group (46.22±10.76) ml, (3.06±0.72) days, (7.17±1.98) days. The operation time (131.29±28.47) minutes was longer than that of the control group (98.54±21.36) minutes (P<0.05). The observation group had shorter self-perceived pain duration (3.86±0.45) days and lower visual analogue scale (VAS) scores at 12 hours postoperatively (4.29±0.47) points versus the control group (4.17±0.59) days, (4.66±0.79) points (P<0.05). At 6 months postoperatively, the observation group exhibited higher myoelectric potential (14.19±2.13) μV, static tension (156.49±21.83) g/cm², and dynamic tension (231.56±28.44) g/cm² than the control group (12.98±1.95) μV, (144.92±22.64) g/cm², (216.47±27.08) g/cm² (P<0.05). At 12 months postoperatively, the observation group had lower pelvic organ prolapse distress inventory 6 (POPDI-6) (6.83±1.51) points, colorectal-anal distress inventory 8 (CRADI-8) (2.27±0.62) points, and urinary distress inventory 6 (UDI-6) (6.76±1.13) points than the control group (7.65±1.79) points, (2.61±0.83) points, (7.43±1.89) points (P<0.05). No statistically significant differences were found in complication rates or POP recurrence rates between the two groups (P>0.05).

Total pelvic floor reconstruction with TiLOOP mesh via laparoscopy reduces intraoperative bleeding, shortens postoperative recovery time, alleviates pain, enhances pelvic floor muscle strength, improves quality of life, and does not increase complications compared to traditional surgery.